Admission Date:  [**2139-5-13**]              Discharge Date:   [**2139-5-17**]  Date of Birth:  [**2066-4-30**]             Sex:   M  Service: MEDICINE  Allergies: Amoxicillin  Attending:[**Last Name (NamePattern1) 1167**] Chief Complaint: DOE  Major Surgical or Invasive Procedure: Cardiac Catheterization s/t stent placement to ramus and LIMA anastamosis Swan [**Last Name (un) 26645**] Catheter Placement   History of Present Illness: 73YO male with hx CAD s/p CABG with redo [**2120**], CHF with EF 30%, afib, DM, CRI, PVD who has recent [**Hospital1 18**] stay last month for decompensated heart failure and ARF that required CCU stay for tailored therapy and CVVH presents today with worsening DOE.
His metolazone has been tepered off and his lasix was increased to 120mg QAM/ 80mg QPM (from 80mg [**Hospital1 **]).
Past Medical History: CAD (CABG [**2109**] AND [**2120**]) CHF w/ EF 30%, diastolic dysfx - recent admit with CCU transfer for tailored therapy [**3-30**].
The patient had a Swan line placed and initially was maintained on dopamine and vasopressin.
Numbers improved when placed on Milrinone.
He was stabilized and transferred back to a floor where he was maintained on Lasix and metolazone with good urine output and faily stable renal function.
AF (dating back to [**2134**]) DM (HBA1c [**2138**] = 7.5) CRI GERD PUD gout claudication s/p CCY s/p cataract [**Doctor First Name **] [**1-30**] s/p back surgery   Social History: Pt is a retired electrial engineer for Ratheon.
Physical Exam: Gen: pleasant, comfortable, mild SOB VS: 98.0 67 94/31 17 100% HEENT: EOMI, anicteric, mild sclerae injection, MMM Neck: supple, JVP at 11-12, no LAD lungs: left basilar rales otherwise CTA bilaterally heart: irregular, HSM across precordium greatest at LSB abd; soft NT ND -h/s megaly, midline hernia with scar ext: 3+ edema bilaterally but L>R (pt states chronic) neuro: CN intact, A&OX3   Pertinent Results: [**2139-5-13**] 11:00PM   CK(CPK)-81 [**2139-5-13**] 11:00PM   CK-MB-NotDone cTropnT-0.44* [**2139-5-13**] 04:19PM   CK(CPK)-106 [**2139-5-13**] 04:19PM   CK-MB-12* MB INDX-11.3* cTropnT-0.52* [**2139-5-13**] 04:19PM   PT-21.2* PTT-37.4* INR(PT)-2.1* [**2139-5-13**] 02:00PM   PT-42.4* PTT-44.4* INR(PT)-4.8* [**2139-5-13**] 01:20PM   CK(CPK)-117 [**2139-5-13**] 01:20PM   CK-MB-15* MB INDX-12.8* cTropnT-0.48* [**2139-5-13**] 01:20PM   PT-40.1* PTT-39.8* INR(PT)-4.5* [**2139-5-13**] 08:50AM   GLUCOSE-137* UREA N-115* CREAT-2.7* SODIUM-137 POTASSIUM-3.2* CHLORIDE-96 TOTAL CO2-26 ANION GAP-18 [**2139-5-13**] 08:50AM   CK(CPK)-120 [**2139-5-13**] 08:50AM   CK-MB-16* MB INDX-13.3* cTropnT-0.40* [**2139-5-13**] 08:50AM   PLT COUNT-104* [**2139-5-13**] 08:50AM   PT-45.6* PTT-40.8* INR(PT)-5.3* [**2139-5-13**] 07:01AM URINE  HOURS-RANDOM UREA N-521 CREAT-69 SODIUM-63 albumin-2.9 alb/CREA-42.0* [**2139-5-13**] 07:01AM URINE  OSMOLAL-373 [**2139-5-13**] 07:01AM URINE  COLOR-Straw APPEAR-Clear SP [**Last Name (un) 155**]-1.010 [**2139-5-13**] 07:01AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2139-5-12**] 10:15PM   GLUCOSE-274* UREA N-119* CREAT-3.0* SODIUM-134 POTASSIUM-4.3 CHLORIDE-92* TOTAL CO2-28 ANION GAP-18 [**2139-5-12**] 10:15PM   ALT(SGPT)-24 AST(SGOT)-22 LD(LDH)-208 CK(CPK)-93 ALK PHOS-144* TOT BILI-0.4 [**2139-5-12**] 10:15PM   cTropnT-0.08* [**2139-5-12**] 10:15PM   CK-MB-NotDone proBNP-5593* [**2139-5-12**] 10:15PM   ALBUMIN-3.8 [**2139-5-12**] 10:15PM   DIGOXIN-1.5 [**2139-5-12**] 10:15PM   WBC-7.5 RBC-3.18* HGB-10.5* HCT-30.9* MCV-97 MCH-32.9* MCHC-33.9 RDW-15.8* [**2139-5-12**] 10:15PM   NEUTS-82.5* LYMPHS-10.5* MONOS-5.6 EOS-0.8 BASOS-0.5 [**2139-5-12**] 10:15PM   MACROCYT-1+ [**2139-5-12**] 10:15PM   PLT COUNT-114* [**2139-5-12**] 10:15PM   PT-49.7* PTT-41.4* INR(PT)-5.9* [**2139-5-12**] 01:15PM   UREA N-108* CREAT-2.8* SODIUM-137 POTASSIUM-3.8 CHLORIDE-93* TOTAL CO2-29 ANION GAP-19 [**2139-5-12**] 01:15PM   MAGNESIUM-2.0 [**2139-5-12**] 01:15PM   DIGOXIN-1.7 [**2139-5-12**] 01:15PM   WBC-7.5 RBC-3.18* HGB-10.5* HCT-31.0* MCV-97 MCH-33.0* MCHC-33.9 RDW-16.0* [**2139-5-12**] 01:15PM   PLT COUNT-134* [**2139-5-12**] 01:15PM   PT-43.2* INR(PT)-4.9* .
Graft Angiography: of 2 saphenous vein bypass grafts was performed using a 5 French right [**Last Name (un) 2699**] catheter, with manual contrast injections.
Percutaneous coronary revascularization was performed using placement of drug-eluting stent(s).
Percutaneous coronary revascularization of an additional vessel was performed using placement of drug-eluting stent(s).
RESISTANCE 174  **% SATURATION DATA (NL) PA MAIN 58 AO 98    **ARTERIOGRAPHY RESULTS MORPHOLOGY % STENOSIS COLLAT.
FROM **LEFT CORONARY 5) LEFT MAIN   NORMAL 6) PROXIMAL LAD   DISCRETE 100 11) INTERMEDIUS   DISCRETE 90 12) PROXIMAL CX   DISCRETE 100  **ARTERIOGRAPHY RESULTS TO SEGMENTS MORPHOLOGY % STENOSIS LOCATION **BYPASS GRAFT 28) SVBG #1   17 NORMAL 29) SVBG #2   14 DISCRETE 100 32) LIMA   7 NORMAL   COMMENTS: 1.
Selective vein graft angiography demonstrated patent SVG-PDA with 80% stenosis in jump segment to the posterolateral branch.
[**2139-5-14**] CXR INDICATION: Swan-Ganz catheter placement.
A Swan-Ganz catheter is present, with the tip making an abrupt rightward turn in the expected location of the junction of the main pulmonary artery and its bifurcation into the left and right pulmonary arteries.
The patient has prior CABG and median sternotomy.
The Swan-Ganz catheter has been removed.
The patient has prior CABG and median sternotomy.
Brief Hospital Course: 73M s/p CABG x 2, CHF EF 20%, AFIB, DM2, abnormal MIBI, p/w worsening SOB/DOE, noted to have NSTEMI via markers.
He had INR reversed in preparation for c. cath and renal consulted for possible CVVH.
At cardiac cath a cypher stent was deployed to the Ramus (3.0x13) and to the LIMA anastomosis (2.5x13).
He was diuresed with lasix 60mm iv, fluid restricted.
Beta blocker held d/t HR, ACE I held d/t renal insufficiency.
Patient is chronically in Afib and coumadin was held (supratherapeutic) for cardiac cath.
He was restarted on coumadin after cath, and no heparin bridge was used.
Digoxin was held d/t elevated level of 1.6, and he is due to restart this medication on the day after discharge, per Dr. [**First Name (STitle) 437**], every other day.
Diabetes was well controlled with FSQID, diabetic diet, RISS.
Vitamin E 400 unit Capsule Sig: One (1) Capsule PO DAILY 2.
Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY 3.
Ferrous Sulfate 325 (65) mg Tab QD 4.
Epoetin Alfa 4,000 unit/mL QMOWEFR (Monday -Wednesday-Friday).
Aspirin 81 mg Tablet QD 6.
Furosemide 80 mg Tablet Sig: One (1) Tablet PO BID 7.
Digoxin 125 mcg Tablet Sig: One (1) Tablet PO DAILY 8.
Nexium 40 mg Capsule, QD 9.
Magnesium Oxide 400 mg Tablet Sig: Two (2) Tablet PO BID * 10 Coumadin 5 mg Tablet Sig: One (1) Tablet PO once a day.
11 Glyburide 1.25 mg Tablet Sig: One (1) Tablet PO once a day.
Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Epoetin Alfa 4,000 unit/mL Solution Sig: 4000 (4000) units/mL Injection QMOWEFR (Monday -Wednesday-Friday).
Vitamin E 400 unit Capsule Sig: One (1) Capsule PO DAILY (Daily).
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Nexium 40 mg Capsule, Delayed Release(E.C.)
Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Warfarin 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
Glyburide 1.25 mg Tablet Sig: One (1) Tablet PO once a day.
Furosemide 80 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Digoxin 125 mcg Tablet Sig: One (1) Tablet PO QOD: Every other day.
Magnesium Oxide 400 mg Tablet Sig: Two (2) Tablet PO twice a day.
Coreg 6.25 mg Tablet Sig: One (1) Tablet PO twice a day.
Adhere to 2 gm sodium diet Fluid Restriction: 1 liter Please note the following changes in your medications: 1) Plavix 75 mg PO QD to prevent clots after stent placement 2) Coreg 6.25 mg PO BID to help with blood pressure and cardiac function 3) Increase ASA to 162 mg PO QD from 81 mg PO QD 4) Digoxin has been changed from 125mcg every day to 125mcg every other day  Followup Instructions: Provider: [**Last Name (NamePattern4) **].
